Chinese vaccine to cost Bangladesh double of India's Oxford-AstraZeneca

The Bangladesh government has approved the purchase of 15 million Covid-19 vaccine doses from China.

Additional Secretary of the Cabinet Division, Shahida Akhter told mediapersons on Thursday had that each dose of China's Sinopharm vaccine will be priced at USD 10.

From June onwards, shipments will arrive in Bangladesh in three phases, with five million doses in each consignment, bdnews24 reported.

This comes after a government cabinet committee approved the USD 150 million government-to-government vaccine deal at a meeting in the capital city Dhaka. According to bdnews24, that means no private companies in Bangladesh will be part of the deal.

Bangladesh had started its inoculation drive against coronavirus with the Oxford-AstraZeneca vaccine procured from India at USD 5 per dose. As things stand, the Chinese vaccine is set to cost Bangladesh double the Oxford-AstraZeneca shot from the Serum India of India.

In the last 24 hours till Saturday morning, Bangladesh recorded another 38 deaths and 1,043 COVID-19 cases, Dhaka Tribune reported. The total number of infections in the country rises to 797,386 and the death toll stands at 12,549.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor